MC, K., J, G., SB, V., F, S., M, B., A, B., . . . M, B. (2025). Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer. Frontiers in neurology, 16, 1530775. https://doi.org/10.3389/fneur.2025.1530775
Chicago Style (17th ed.) CitationMC, Kielkopf, et al. "Anticoagulant Versus Antiplatelet Treatment for Secondary Stroke Prevention in Patients with Active Cancer." Frontiers in Neurology 16 (2025): 1530775. https://doi.org/10.3389/fneur.2025.1530775.
MLA (9th ed.) CitationMC, Kielkopf, et al. "Anticoagulant Versus Antiplatelet Treatment for Secondary Stroke Prevention in Patients with Active Cancer." Frontiers in Neurology, vol. 16, 2025, p. 1530775, https://doi.org/10.3389/fneur.2025.1530775.
Warning: These citations may not always be 100% accurate.
